(Q33979654)

30 July 2017

Midodrine, octreotide, albumin, and TIPS in selected patients with cirrhosis and type 1 hepatorenal syndrome (English)

1 reference

30 July 2017

0 references

Florence Wong

1

1 reference

30 July 2017

Lavinia Pantea

series ordinal

2

1 reference

30 July 2017

Kenneth Sniderman

series ordinal

3

1 reference

30 July 2017

language of work or name

English

0 references

publication date

1 July 2004

1 reference

30 July 2017

1 reference

30 July 2017

40

1 reference

30 July 2017

1

1 reference

30 July 2017

55-64

1 reference

Transjugular intrahepatic portosystemic stent shunt: effects on hemodynamics and sodium homeostasis in cirrhosis and refractory ascites.

30 July 2017

1 reference

Reduction in renal blood flow following acute increase in the portal pressure: evidence for the existence of a hepatorenal reflex in man?

21 January 2018

1 reference

Definition and diagnostic criteria of refractory ascites and hepatorenal syndrome in cirrhosis. International Ascites Club

21 January 2018

1 reference

7 January 2021

Incidence, predictive factors, and prognosis of the hepatorenal syndrome in cirrhosis with ascites

1 reference

7 January 2021

Recovery from “Hepatorenal Syndrome” after Orthotopic Liver Transplantation

1 reference

7 January 2021

Hepatorenal syndrome in cirrhosis: pathogenesis and treatment

1 reference

7 January 2021

Terlipressin in patients with cirrhosis and type 1 hepatorenal syndrome: a retrospective multicenter study

1 reference

7 January 2021

Effects of noradrenalin and albumin in patients with type I hepatorenal syndrome: a pilot study

1 reference

7 January 2021

Reversal of type 1 hepatorenal syndrome with the administration of midodrine and octreotide

1 reference

7 January 2021

Octreotide in hepatorenal syndrome: a randomized, double-blind, placebo-controlled, crossover study

1 reference

7 January 2021

Long term outcome after transjugular intrahepatic portosystemic stent-shunt in non-transplant cirrhotics with hepatorenal syndrome: a phase II study

1 reference

7 January 2021

Transjugular intrahepatic portosystemic shunt in hepatorenal syndrome: Effects on renal function and vasoactive systems

1 reference

7 January 2021

The mechanism of the initial natriuresis after transjugular intrahepatic portosystemic shunt

1 reference

7 January 2021

Signed consent for publication

1 reference

7 January 2021

The mechanism of improved sodium homeostasis of low-dose losartan in preascitic cirrhosis

1 reference

7 January 2021

Central blood volume in cirrhosis: measurement with radionuclide angiography

1 reference

7 January 2021

Transjugular intrahepatic portosystemic shunt for refractory ascites: Tipping the sodium balance

1 reference

7 January 2021

Is sinusoidal portal hypertension a necessary factor for the development of hepatic ascites?

1 reference

7 January 2021

The North American Study for the Treatment of Refractory Ascites

1 reference

7 January 2021

Transjugular intrahepatic portosystemic shunting versus paracentesis plus albumin for refractory ascites in cirrhosis

1 reference

7 January 2021

Determination of catecholamines in rat heart tissue and plasma samples by liquid chromatography with electrochemical detection

1 reference

7 January 2021

Electrochemical detection of catecholamines in urine and plasma after separation with HPLC

1 reference

7 January 2021

The renal clearance of alkali-stable inulin

1 reference

7 January 2021

Peripheral arterial vasodilation hypothesis: a proposal for the initiation of renal sodium and water retention in cirrhosis.

1 reference

7 January 2021

Impaired reactivity of the peripheral vasculature to pressor agents in alcoholic cirrhosis

1 reference

7 January 2021

Role of small-conductance Ca2+-dependent K+ channels in in vitro nitric oxide-mediated aortic hyporeactivity to alpha-adrenergic vasoconstriction in rats with cirrhosis.

1 reference

7 January 2021

Elevated nitric oxide levels in patients with chronic liver disease and cirrhosis correlate with disease stage and parameters of hyperdynamic circulation.

1 reference

7 January 2021

Influence of the degree of liver failure on systemic and splanchnic haemodynamics and on response to propranolol in patients with cirrhosis

1 reference

7 January 2021

Review article: pharmacological treatment of the hepatorenal syndrome in cirrhotic patients

1 reference

7 January 2021

Improvement of hepatorenal syndrome with extracorporeal albumin dialysis MARS: results of a prospective, randomized, controlled clinical trial

1 reference

7 January 2021

Pentoxifylline improves short-term survival in severe acute alcoholic hepatitis: a double-blind, placebo-controlled trial

1 reference

7 January 2021

Long-term survival and renal function following liver transplantation in patients with and without hepatorenal syndrome--experience in 300 patients

1 reference

7 January 2021

Effects of treatment of hepatorenal syndrome before transplantation on posttransplantation outcome. A case-control study.

1 reference

7 January 2021

Identifiers

DOI

10.1002/HEP.20262

1 reference

30 July 2017

1 reference